<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK447258" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK447258/" /><meta name="ncbi_pagename" content="VPS35-Related Parkinson Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>VPS35-Related Parkinson Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="VPS35-Related Parkinson Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/08/10" /><meta name="citation_author" content="Angela Deutschländer" /><meta name="citation_author" content="Owen A Ross" /><meta name="citation_author" content="Zbigniew K Wszolek" /><meta name="citation_pmid" content="28796472" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK447258/" /><meta name="citation_keywords" content="PARK17" /><meta name="citation_keywords" content="PARK17" /><meta name="citation_keywords" content="Vacuolar protein sorting-associated protein 35" /><meta name="citation_keywords" content="VPS35" /><meta name="citation_keywords" content="VPS35-Related Parkinson Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="VPS35-Related Parkinson Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Angela Deutschländer" /><meta name="DC.Contributor" content="Owen A Ross" /><meta name="DC.Contributor" content="Zbigniew K Wszolek" /><meta name="DC.Date" content="2017/08/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK447258/" /><meta name="description" content="VPS35-related Parkinson disease (VPS35-PD) is defined as Parkinson disease caused by heterozygous VPS35 pathogenic variants. Currently, the only known VPS35 variant with confirmed pathogenicity is c.1858G&gt;A (p.Asp620Asn). Except for a younger age of onset, VPS35-PD is clinically indistinguishable from Parkinson disease of unknown cause (so-called sporadic Parkinson disease). Variability among 50 individuals reported with molecularly confirmed VPS35-PD includes age of onset (mean: 51.0±8.7 years; range: 34-68 years), Parkinson subtype (tremor, akinetic rigid, mixed), first motor symptom, course of the disease (unilateral onset and slow disease progression are typical; dyskinesia and motor fluctuations may occur), and presence/absence of neuropsychiatric manifestations (including depression, schizophrenia, learning difficulties, mild cognitive impairment, and dementia)." /><meta name="og:title" content="VPS35-Related Parkinson Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="VPS35-related Parkinson disease (VPS35-PD) is defined as Parkinson disease caused by heterozygous VPS35 pathogenic variants. Currently, the only known VPS35 variant with confirmed pathogenicity is c.1858G&gt;A (p.Asp620Asn). Except for a younger age of onset, VPS35-PD is clinically indistinguishable from Parkinson disease of unknown cause (so-called sporadic Parkinson disease). Variability among 50 individuals reported with molecularly confirmed VPS35-PD includes age of onset (mean: 51.0±8.7 years; range: 34-68 years), Parkinson subtype (tremor, akinetic rigid, mixed), first motor symptom, course of the disease (unilateral onset and slow disease progression are typical; dyskinesia and motor fluctuations may occur), and presence/absence of neuropsychiatric manifestations (including depression, schizophrenia, learning difficulties, mild cognitive impairment, and dementia)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK447258/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/vps35-pd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK447258/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CAEC7E03FDE4100000000079602C9.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK447258_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK447258_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/vps13d-md/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/porphyria-var/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK447258_"><span class="title" itemprop="name"><i>VPS35</i>-Related Parkinson Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: PARK17</div><p class="contrib-group"><span itemprop="author">Angela Deutschl&#x000e4;nder</span>, MD, <span itemprop="author">Owen A Ross</span>, PhD, and <span itemprop="author">Zbigniew K Wszolek</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK447258_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK447258_ai__"><div class="contrib half_rhythm"><span itemprop="author">Angela Deutschl&#x000e4;nder</span>, MD<div class="affiliation small">Departments of Neurology, Neuroscience, and Clinical Genomics<br />Mayo Clinic<br />Jacksonville, Florida</div></div><div class="contrib half_rhythm"><span itemprop="author">Owen A Ross</span>, PhD<div class="affiliation small">Departments of Neuroscience and Clinical Genomics<br />Mayo Clinic<br />Jacksonville, Florida</div></div><div class="contrib half_rhythm"><span itemprop="author">Zbigniew K Wszolek</span>, MD<div class="affiliation small">Department of Neurology<br />Mayo Clinic<br />Jacksonville, Florida</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 10, 2017</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="vps35-pd.Summary" itemprop="description"><h2 id="_vps35-pd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>VPS35</i>-related Parkinson disease (<i>VPS35</i>-PD) is defined as Parkinson disease caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>VPS35</i> pathogenic variants. Currently, the only known <i>VPS35</i> variant with confirmed pathogenicity is c.1858G&#x0003e;A (p.Asp620Asn). Except for a younger age of onset, <i>VPS35</i>-PD is clinically indistinguishable from Parkinson disease of unknown cause (so-called <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> Parkinson disease). Variability among 50 individuals reported with molecularly confirmed <i>VPS35</i>-PD includes age of onset (mean: 51.0&#x000b1;8.7 years; range: 34-68 years), Parkinson subtype (tremor, akinetic rigid, mixed), first motor symptom, course of the disease (unilateral onset and slow disease progression are typical; dyskinesia and motor fluctuations may occur), and presence/absence of neuropsychiatric manifestations (including depression, schizophrenia, learning difficulties, mild cognitive impairment, and dementia).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>VPS35</i>-PD is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with at least two cardinal manifestations of Parkinson disease and the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.1858G&#x0003e;A (p.Asp620Asn) identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> To date, treatment of <i>VPS35</i>-PD does not differ from that of Parkinson disease in general. Drugs to treat motor manifestations include the precursor of dopamine, levodopa, in combination with a peripheral dopa decarboxylase inhibitor (carbidopa, benserazide), dopamine agonists, inhibitors of catechol-O-methyltransferase (COMT) or monoamine oxidase-B (MAO-B), anticholinergics, and amantadine. A good response to levodopa is usually seen. Deep brain stimulation to the subthalamic nucleus is effective in treating motor fluctuations or dyskinesia. Effective treatments for neuropsychiatric and autonomic symptoms, which may be disabling, are limited. Patients benefit from physical, occupational, and speech therapies.</p><p><i>Surveillance:</i> Follow-up clinical neurologic evaluations are recommended every three to 12 months (depending on clinical scenario) to assess tremor, hypokinesia, rigidity, gait, cognition, and neuropsychiatric symptoms as well as treatment effectiveness.</p><p><i>Agents/circumstances to avoid:</i> Drugs that may induce or exacerbate parkinsonism include but are not limited to neuroleptics, antidepressants, calcium channel blockers, valproate, lithium, and amiodarone.</p><p><i>Pregnancy management:</i> No reports have addressed pregnancy management in women with <i>VPS35</i>-PD.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>VPS35</i>-PD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. About 85% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have an affected parent. Although about 15% of affected individuals are <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family), family data are insufficient to determine if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. Each child of an individual with <i>VPS35</i>-PD has a 50% chance of inheriting the <i>VPS35</i> pathogenic variant. Once the <i>VPS35</i> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="vps35-pd.Diagnosis"><h2 id="_vps35-pd_Diagnosis_">Diagnosis</h2><p>Diagnostic criteria for Parkinson disease have been published [<a class="bk_pop" href="#vps35-pd.REF.berardelli.2013.16">Berardelli et al 2013</a>, <a class="bk_pop" href="#vps35-pd.REF.postuma.2015.1591">Postuma et al 2015</a>].</p><div id="vps35-pd.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>VPS35</i>-related Parkinson disease (<i>VPS35</i>-PD) <b>should be considered</b> in individuals with the following clinical and imaging findings (characteristic of all forms of PD) and a family history of PD.</p><p><b>Clinical findings</b></p><p>Cardinal manifestations of Parkinson disease including:</p><ul><li class="half_rhythm"><div>Resting tremor (rhythmic tremor usually of the hands and forearms when relaxed, which disappears with active limb movement)</div></li><li class="half_rhythm"><div>Hypokinesia (partial or complete loss of muscle movement)</div></li><li class="half_rhythm"><div>Rigidity (increased muscle tone resulting in resistance to passive movement)</div></li><li class="half_rhythm"><div>Disturbance of postural reflexes (which maintain posture during movement)</div></li></ul><p>Additional clinical characteristics:</p><ul><li class="half_rhythm"><div>Adult onset</div></li><li class="half_rhythm"><div>Typically unilateral onset</div></li><li class="half_rhythm"><div>Slow disease progression</div></li><li class="half_rhythm"><div>Good response to levodopa therapy</div></li></ul><p><b>Neuroimaging.</b> Normal cranial MRI</p><p><b>Family history</b> consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance, which can also include <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></p></div><div id="vps35-pd.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>VPS35</i>-PD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with least two cardinal manifestations of Parkinson disease and the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK447258/table/vps35-pd.T.vps35_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figvps35pdTvps35variantsdiscussedint" rid-ob="figobvps35pdTvps35variantsdiscussedint">c.1858G&#x0003e;A</a> (p.Asp620Asn) identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK447258/table/vps35-pd.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figvps35pdTmoleculargenetictestinguse" rid-ob="figobvps35pdTmoleculargenetictestinguse">Table 1</a>). Note: To date, this is the only <i>VPS35</i> variant with confirmed pathogenicity. Other variants have been identified in persons with Parkinson disease but their pathogenicity remains equivocal (see <a href="#vps35-pd.Molecular_Genetics">Molecular Genetics</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the phenotypes of inherited Parkinson disease are largely indistinguishable, most individuals with <i>VPS35</i>-PD are diagnosed by the following <a href="#vps35-pd.Recommended_Testing">recommended testing</a> or <a href="#vps35-pd.Testing_to_Consider">testing to be considered</a>.</p><div id="vps35-pd.Recommended_Testing"><h4>Recommended Testing</h4><p><b>A multigene Parkinson disease panel</b> including <i>VPS35</i> and other genes of interest (see <a href="#vps35-pd.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Given the rarity of <i>VPS35</i>-related Parkinson disease, some panels for Parkinson disease may not include this gene.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="vps35-pd.Testing_to_Consider"><h4>Testing to Consider</h4><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> (when clinically available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and genome sequencing. For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>VPS35</i>) is typically not recommended. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> overlaps with that of other inherited forms of Parkinson disease, a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> are typically used in lieu of single-gene testing.</p><div id="vps35-pd.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>VPS35</i>-Related Parkinson Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447258/table/vps35-pd.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps35-pd.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>VPS35</i></td><td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24/24&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="vps35-pd.TF.1.1"><p class="no_margin">See <a href="/books/NBK447258/#vps35-pd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="vps35-pd.TF.1.2"><p class="no_margin">See <a href="#vps35-pd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="vps35-pd.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Variants detected may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="vps35-pd.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al [2011]</a>, <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al [2011]</a>, <a class="bk_pop" href="#vps35-pd.REF.ando.2012.1413">Ando et al [2012]</a>, <a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al [2012]</a>, <a class="bk_pop" href="#vps35-pd.REF.lesage.2012.1449">Lesage et al [2012]</a>, <a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al [2012]</a>, <a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al [2012]</a></p></div></dd><dt>5. </dt><dd><div id="vps35-pd.TF.1.5"><p class="no_margin">To date, the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Asp620Asn has been found in four <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and 20 probands (index patients) with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Parkinson disease.</p></div></dd><dt>6. </dt><dd><div id="vps35-pd.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="vps35-pd.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al [2011]</a>, <a class="bk_pop" href="#vps35-pd.REF.verstraeten.2012.1844.e11">Verstraeten et al [2012]</a></p></div></dd></dl></div></div></div></div></div></div><div id="vps35-pd.Clinical_Characteristics"><h2 id="_vps35-pd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="vps35-pd.Clinical_Description"><h3>Clinical Description</h3><p>To date, 24 probands with molecularly confirmed <i>VPS35</i>-related Parkinson disease (i.e., due to the p.Asp620Asn <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) have been reported [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.ando.2012.1413">Ando et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</a>]; 20 were <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and four were <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (a single occurrence of <i>VPS35</i>-PD in a family). By testing at-risk relatives in the 20 familial cases, the authors confirmed the diagnosis of <i>VPS35</i>-PD in 26 additional individuals worldwide, bringing to 50 the total of number of individuals with molecularly confirmed <i>VPS35</i>-PD.</p><p>Except for a younger age of onset, <i>VPS35</i>-PD is clinically undistinguishable from Parkinson disease of unknown cause. Variability within families with <i>VPS35</i>-PD includes age of onset, first motor symptom, prevailing motor manifestations throughout the course of the disease, and presence/absence of neuropsychiatric manifestations (e.g., depression, dementia).</p><p><b>Age of onset.</b> Mean age at disease onset is 51.0&#x000b1;8.7 years (range: 34-68 years; n=50); 51.2% are female (22/43).</p><p><b>Parkinson subtype.</b> While the tremor-dominant subtype of Parkinson disease (with leg tremor as the initial manifestation) was thought to be common [<a class="bk_pop" href="#vps35-pd.REF.wider.2008.465">Wider et al 2008</a>], subsequently reported families had akinetic rigid and mixed subtypes of Parkinson disease, and some individuals never developed tremor [<a class="bk_pop" href="#vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</a>].</p><p><b>Course of the disease</b></p><ul><li class="half_rhythm"><div>Asymmetric presentation at disease onset is typical.</div></li><li class="half_rhythm"><div>The disease course is usually slowly progressive.</div></li><li class="half_rhythm"><div>Dyskinesia and motor fluctuations may occur.</div><div>Of note, atypical motor findings, cerebellar signs, or ocular motor signs have not been reported.</div></li></ul><p><b>Neuropsychiatric manifestations</b></p><ul><li class="half_rhythm"><div>Depression has been reported occasionally; in one family depression was common [<a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>].</div></li><li class="half_rhythm"><div>In one family with <i>VPS35</i>-PD, schizophrenia was reported in two family members with Parkinson disease; however, it was not explicitly stated that the two individuals had been tested for the p.Asp620Asn variant [<a class="bk_pop" href="#vps35-pd.REF.wider.2008.465">Wider et al 2008</a>, <a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>].</div></li><li class="half_rhythm"><div>Learning difficulties, mild cognitive impairment, and dementia have been reported in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul><p><b>Other findings reported</b></p><ul><li class="half_rhythm"><div>Impaired sense of smell [<a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.struhal.2014.755">Struhal et al 2014</a>]</div></li><li class="half_rhythm"><div>Autonomic manifestations including orthostasis and gastrointestinal symptoms (constipation)</div></li></ul><p><b>Functional imaging studies</b> show presynaptic dopaminergic dysfunction, which is apparently indistinguishable from findings in Parkinson disease in general.</p><p>Single photon emission computed tomography (SPECT) of cerebral blood flow was normal in one individual [<a class="bk_pop" href="#vps35-pd.REF.ando.2012.1413">Ando et al 2012</a>].</p><p><sup>18</sup>F-fluorodopa positron emission tomography (PET) showed asymmetrically reduced striatal <sup>18</sup>F-fluorodopa uptake with a posterior predominance [<a class="bk_pop" href="#vps35-pd.REF.wider.2008.465">Wider et al 2008</a>].</p><p>[123I]-FP-CIT SPECT showed asymmetric tracer uptake [<a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>].</p><p><b>Transcranial sonography.</b> In one individual with Parkinson disease that started with resting tremor on the left side, transcranial sonography performed after a disease course of about 15 years showed normal echogenicity of the left substantia nigra, whereas the bone window was insufficient to allow visualization on the right side [<a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</a>].</p></div><div id="vps35-pd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is possible as p.Asp620Asn is the only confirmed <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to date.</p></div><div id="vps35-pd.Penetrance"><h3>Penetrance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the p.Asp620Asn variant is high and age dependent [<a class="bk_pop" href="#vps35-pd.REF.trinh.2014.1535">Trinh et al 2014</a>, <a class="bk_pop" href="#vps35-pd.REF.lill.2016.386">Lill 2016</a>]. Of note, to date data are too limited to allow quantification of penetrance.</p><p>Age-dependent <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> (onset range: 34-68 years) is most likely reflected in the following information on ten unaffected individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the p.Asp620Asn variant identified in families with <i>VPS35</i>-PD:</p><ul><li class="half_rhythm"><div>Six were age 62 years or younger [<a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</a>].</div></li><li class="half_rhythm"><div>Four were between ages 49 and 67 years [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>].</div></li></ul><p>The p.Asp620Asn variant is very rare and was not found in:</p><ul><li class="half_rhythm"><div>Control groups screened for <i>VPS35</i> variants, including <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al [2011]</a>, <a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al [2011]</a>, and <a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al [2012]</a> &#x02013; of which the largest study [<a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al 2012</a>] had 6,513 individuals;</div></li><li class="half_rhythm"><div>The Genome Aggregation Database (gnomAD), which contains data for 123,136 exomes and 15,496 whole genomes [<a class="bk_pop" href="#vps35-pd.REF.lek.2016.285">Lek et al 2016</a>].</div></li></ul></div><div id="vps35-pd.Nomenclature"><h3>Nomenclature</h3><p><i>VPS35</i>-related Parkinson disease is also referred to as "PARK-VPS35" per the alternative nomenclature system proposed by <a class="bk_pop" href="#vps35-pd.REF.marras.2012.1016">Marras et al [2012]</a>.</p></div><div id="vps35-pd.Prevalence"><h3>Prevalence</h3><p>To date 24 probands with <i>VPS35</i>-related Parkinson disease have been reported worldwide [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.ando.2012.1413">Ando et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</a>]. Twenty were <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and four were <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (a single occurrence of <i>VPS35</i>-PD in a family). By testing relatives at risk in the 20 familial cases, the authors confirmed the diagnosis of <i>VPS35</i>-PD in an additional 26 individuals.</p><p>Nine studies with sample sizes greater than 500 patients with PD are available. They comprise a total of 19,294 individuals. In these nine studies, the <i>VPS35</i> p.Asp620Asn variant was identified in 12 <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> index cases and three <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.ando.2012.1413">Ando et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.guo.2012.983">Guo et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.zhang.2012.638">Zhang et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.chen.2013.1709.e7">Chen et al 2013</a>].</p><p>The prevalence of <i>VPS35</i>-PD ranged from 0.0% to 1.5% in the following specific patient populations, which only included persons with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> PD:</p><ul><li class="half_rhythm"><div>2:131 in Austria [<a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>]</div></li><li class="half_rhythm"><div>3:246 in France [<a class="bk_pop" href="#vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</a>]</div></li><li class="half_rhythm"><div>3:300 in Japan [<a class="bk_pop" href="#vps35-pd.REF.ando.2012.1413">Ando et al 2012</a>]</div></li><li class="half_rhythm"><div>1:191 in the UK [<a class="bk_pop" href="#vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</a>]</div></li><li class="half_rhythm"><div>0:475 and 0:250 in Italy [<a class="bk_pop" href="#vps35-pd.REF.guella.2012.800">Guella et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.gagliardi.2014.2422.e1">Gagliardi et al 2014</a>]</div></li></ul><p>In one study (including both <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases) <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> frequencies were 2:120 in Yemenite Jews and 1:199 in Tunisians [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>].</p><p>The p.Asp620Asn variant was not found in 11 studies involving individuals with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Parkinson disease from Europe, the US, South Africa, China (4 studies), and India [<a class="bk_pop" href="#vps35-pd.REF.deng.2012.e96">Deng et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.guo.2012.983">Guo et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.verstraeten.2012.1844.e11">Verstraeten et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.zhang.2012.638">Zhang et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.chen.2013.1709.e7">Chen et al 2013</a>, <a class="bk_pop" href="#vps35-pd.REF.nuytemans.2013.982">Nuytemans et al 2013</a>, <a class="bk_pop" href="#vps35-pd.REF.sudhaman.2013.2442.e1">Sudhaman et al 2013</a>, <a class="bk_pop" href="#vps35-pd.REF.blanckenberg.2014.445.e1">Blanckenberg et al 2014</a>, <a class="bk_pop" href="#vps35-pd.REF.kalinderi.2015.113">Kalinderi et al 2015</a>, <a class="bk_pop" href="#vps35-pd.REF.bandr_sciga.2016.210.e1">Bandr&#x000e9;s-Ciga et al 2016</a>, <a class="bk_pop" href="#vps35-pd.REF.t_r_k.2016.135">T&#x000f6;r&#x000f6;k et al 2016</a>].</p><p>The frequency of the <i>VPS35</i> p.Asp620Asn variant in the general (control) population is very low, and not exactly determined.</p></div></div><div id="vps35-pd.Genetically_Related_Allelic_Dis"><h2 id="_vps35-pd_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>A second <i>VPS35</i> variant, p.Leu625Pro, was found <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in one individual with early-onset Alzheimer disease [<a class="bk_pop" href="#vps35-pd.REF.roveletlecrux.2015.1046">Rovelet-Lecrux et al 2015</a>]; however, data to date are too limited to determine if the Alzheimer disease in this individual resulted from the <i>VPS35</i> variant or was coincidental.</p></div><div id="vps35-pd.Differential_Diagnosis"><h2 id="_vps35-pd_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of <i>VPS35</i>-related Parkinson disease (<i>VPS35</i>-PD) includes <b>Parkinson disease of unknown cause</b> (sometimes referred to as <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> or <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> Parkinson disease). Apart from a younger age at onset, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>VPS35</i>-PD (onset at age 50.2&#x000b1;8.9 years) is clinically indistinguishable from sporadic Parkinson disease (average onset at 60 years). Thus, the differential diagnosis of <i>VPS35</i>-PD is the same as it is for PD in general (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>). In addition, an extensive list of differential diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> parkinsonism can be found in the book chapter by <a class="bk_pop" href="#vps35-pd.REF.fujioka.2014">Fujioka &#x00026; Wszolek [2014]</a>.</p></div><div id="vps35-pd.Management"><h2 id="_vps35-pd_Management_">Management</h2><div id="vps35-pd.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>VPS35</i>-related Parkinson disease, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Perform neurologic examination including assessment of tremor, hypokinesia, rigidity, postural reflexes, gait (propulsion, arm swing, stride length), and autonomic findings (e.g., orthostasis).</div></li><li class="half_rhythm"><div>Assess cognitive function and psychiatric manifestations (e. g., hallucinations, delusions, depression, anxiety, sleep disorders).</div></li><li class="half_rhythm"><div>Evaluate levodopa response.</div></li><li class="half_rhythm"><div>Consider consultation with a clinical geneticist and/or genetic counselor.</div></li></ul></div><div id="vps35-pd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>To date, the treatment of individuals with <i>VPS35</i>-PD does not differ from that of Parkinson disease in general. The following is a brief summary of recommended treatment for PD, based on extensive existing guidelines and recommendations for pharmacotherapy of motor and non-motor manifestations of PD as well as neurosurgical interventions for motor findings [<a class="bk_pop" href="#vps35-pd.REF.zesiewicz.2010.924">Zesiewicz et al 2010</a>, <a class="bk_pop" href="#vps35-pd.REF.oertel.a">Oertel et al 2011a</a>, <a class="bk_pop" href="#vps35-pd.REF.oertel.b">Oertel et al 2011b</a>, <a class="bk_pop" href="#vps35-pd.REF.seppi.2011.s42">Seppi et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.ferreira.2013.5">Ferreira et al 2013</a>, <a class="bk_pop" href="#vps35-pd.REF.odin.2015.1133">Odin et al 2015</a>, <a class="bk_pop" href="#vps35-pd.REF.trenkwalder.2015.1023">Trenkwalder et al 2015</a>].</p><p><b>Pharmacotherapy.</b> Drugs to treat motor manifestations include the precursor of dopamine, levodopa, in combination with a peripheral dopa decarboxylase inhibitor (carbidopa, benserazide), dopamine agonists, inhibitors of catechol-O-methyltransferase (COMT) or monoamine oxidase-B (MAO-B), anticholinergics, and amantadine. A good levodopa response was seen in nearly all reported individuals with <i>VPS35</i>-PD.</p><p>General recommendations for treatment of Parkinson disease of unknown cause include the following:</p><ul><li class="half_rhythm"><div>To reduce or delay side effects (e.g., dyskinesias, hallucinations, impulse control disorder) of levodopa and dopaminergic medication, doses should not exceed the levels required for a satisfactory clinical response. In younger patients, dopamine agonists should be given a preference.</div></li><li class="half_rhythm"><div>Dyskinesias can be treated with reduction of levodopa doses, use of dopamine receptor agonists, deep-brain stimulation, and continuous application of levodopa or apomorphine.</div></li><li class="half_rhythm"><div>Patients treated with ergot-derived dopamine agonists require periodic echocardiograms. Ergot-derived dopaminergic drugs should be discontinued if fibrotic heart-valve changes are revealed [<a class="bk_pop" href="#vps35-pd.REF.antonini.2007.826">Antonini &#x00026; Poewe 2007</a>].</div></li></ul><p><b>Deep brain stimulation</b> to the subthalamic nucleus was repeatedly reported to be effective in the treatment of disabling motor fluctuations or dyskinesia in persons with <i>VPS35</i>-PD.</p><p><b>Other.</b> Overall, effective treatment for neuropsychiatric and autonomic symptoms (which may be disabling) is limited. Atypical neuroleptic agents such as low-dose clozapine and reduction of dopaminergic therapy can decrease delusions and hallucinations. If depression occurs, it should be treated according to guidelines. Droxidopa may be used to treat orthostasis.</p><p>Patients also benefit from physical, occupational, and speech therapy.</p></div><div id="vps35-pd.Surveillance"><h3>Surveillance</h3><p>For <i>VPS35</i>-PD (as well as in Parkinson disease in general), follow-up clinical neurologic evaluations are recommended every three to 12 months (depending on the clinical scenario and the needs of the individual) to assess tremor, hypokinesia, rigidity, gait, cognition, and neuropsychiatric symptoms as well as treatment effectiveness.</p></div><div id="vps35-pd.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Neuroleptic drugs may increase the severity of parkinsonism in <i>VPS35</i>-PD (as in Parkinson disease in general). In general, atypical neuroleptics are less likely to exacerbate parkinsonism than typical neuroleptics. Other drugs that may induce or exacerbate parkinsonism include but are not limited to antidepressants, calcium channel blockers, valproate, lithium, and amiodarone [<a class="bk_pop" href="#vps35-pd.REF.bondonguitton.2011.2226">Bondon-Guitton et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.bohlega.2013.215">Bohlega &#x00026; Al-Foghom 2013</a>].</p></div><div id="vps35-pd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#vps35-pd.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="vps35-pd.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Reports addressing pregnancy management in women with <i>VPS35</i>-PD are not available. The effect of PD in general on pregnancy has not been well characterized, since pregnancy is uncommon in women with PD. While most reports indicate that disease manifestations worsen during pregnancy, improvement has also been described (for a review see <a class="bk_pop" href="#vps35-pd.REF.robottom.2008.1799">Robottom et al [2008]</a>, <a class="bk_pop" href="#vps35-pd.REF.kranick.2010.665">Kranick et al [2010]</a>).</p><p>No long-term outcome data exist for children born to mothers with Parkinson disease.</p><ul><li class="half_rhythm"><div>Levodopa crosses the placenta and some animal models have shown that high doses of levodopa administered during pregnancy may induce skeletal and visceral malformations; however, in more than 30 cases reported in the literature, levodopa treatment during human pregnancy did not result in adverse fetal outcome [<a class="bk_pop" href="#vps35-pd.REF.scott.2005.1078">Scott &#x00026; Chowdhury 2005</a>].</div></li><li class="half_rhythm"><div>Amantadine should be avoided during pregnancy, if possible, since adverse pregnancy outcomes have been reported in rats.</div></li></ul><p>Discussion of the risks and benefits of using a given medication during pregnancy should ideally take place prior to conception. See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="vps35-pd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="vps35-pd.Genetic_Counseling"><h2 id="_vps35-pd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="vps35-pd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>VPS35</i>-related Parkinson disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="vps35-pd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>About 85% of individuals diagnosed with <i>VPS35</i>-PD have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Intrafamilial variability is seen in age of disease onset, first motor symptom, prevailing motor manifestations, and presence/absence of neuropsychiatric manifestations (e.g., depression, dementia).</div></li><li class="half_rhythm"><div>About 15% of individuals with <i>VPS35</i>-PD represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family); however, the parents of these individuals have not been evaluated sufficiently to determine if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a><i>.</i> Therefore, the proportion of <i>VPS35</i>-PD caused by a <i>de novo</i> pathogenic variant is unknown. Of note: Because the p.Asp620Asn variant is known to occur on different haplotypes, it is likely a mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. No instances of germline mosaicism have been reported, although it is theoretically possible.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>VPS35</i>-PD may appear to be negative because of failure to recognize the disorder in family members, age-related or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the disease in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent, or early death of the parent before the onset of disease manifestations. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. The risk to sibs who inherit the <i>VPS35</i> pathogenic variant of developing disease increases with age (see <a href="#vps35-pd.Penetrance">Penetrance</a>).</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for <i>VPS35</i>-PD because of the possibility of age-related or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric risk to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#vps35-pd.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with <i>VPS35</i>-PD has a 50% chance of inheriting the <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The probability that an offspring who has inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will become symptomatic increases with age (see <a href="#vps35-pd.Penetrance">Penetrance</a>).</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="vps35-pd.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p><b>Predictive testing (i.e., testing of asymptomatic, at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once the p.Asp620Asn <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. The utility of predictive testing for a known <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>VPS35</i> pathogenic variant may be limited because current data suggest both age-related and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in <i>VPS35</i>-PD (see <a href="#vps35-pd.Penetrance">Penetrance</a>) [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.trinh.2014.1535">Trinh et al 2014</a>].</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals found to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years)</b></p><ul><li class="half_rhythm"><div>For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>Note: It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of <i>VPS35</i>-PD.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="vps35-pd.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="vps35-pd.Resources"><h2 id="_vps35-pd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Parkinson Disease Association (APDA)</b></div><div>135 Parkinson Avenue</div><div>Staten Island NY 10305</div><div><b>Phone:</b> 800-223-2732 (toll-free); 718-981-8001</div><div><b>Fax:</b> 718-981-4399</div><div><b>Email:</b> apda@apdaparkinson.org</div><div><a href="http://www.apdaparkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apdaparkinson.org</a></div></li><li class="half_rhythm"><div><b>Fox Trial Finder</b></div><div><a href="https://foxtrialfinder.michaeljfox.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">foxtrialfinder.michaeljfox.org/</a></div></li><li class="half_rhythm"><div><b>Michael J. Fox Foundation for Parkinson's Research</b></div><div>Church Street Station</div><div>PO Box 780</div><div>New York NY 10008-0780</div><div><b>Phone:</b> 800-708-7644 (toll-free)</div><div><b>Email:</b> info@michaeljfox.org</div><div><a href="http://www.michaeljfox.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.michaeljfox.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Parkinson%27s%20disease&#x00026;parent=Disease%20Risk&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson Disease</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=parkinsondisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson disease</a></div></li><li class="half_rhythm"><div><b>Parkinson's Foundation</b></div><div>200 SE 1st Street</div><div>Suite 800</div><div>Miami FL 33131</div><div><b>Phone:</b> 800-4PD-INFO (473-4636)</div><div><b>Email:</b> contact@parkinson.org</div><div><a href="http://www.parkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parkinson.org</a></div></li></ul></div><div id="vps35-pd.Molecular_Genetics"><h2 id="_vps35-pd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="vps35-pd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>VPS35-Related Parkinson Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447258/table/vps35-pd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps35-pd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_vps35-pd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_vps35-pd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_vps35-pd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_vps35-pd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_vps35-pd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_vps35-pd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55737" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>VPS35</i></a></td><td headers="hd_b_vps35-pd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55737" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_vps35-pd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96QK1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vacuolar protein sorting-associated protein 35</a></td><td headers="hd_b_vps35-pd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=VPS35" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS35</a></td><td headers="hd_b_vps35-pd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=VPS35[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS35</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="vps35-pd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="vps35-pd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for VPS35-Related Parkinson Disease (<a href="/omim/601501,614203" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447258/table/vps35-pd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps35-pd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601501" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601501</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VACUOLAR PROTEIN SORTING 35, YEAST, HOMOLOG OF; VPS35</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614203" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614203</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PARKINSON DISEASE 17; PARK17</td></tr></tbody></table></div></div><div id="vps35-pd.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><b>Gene structure.</b>
<i>VPS35</i> consists of approximately 29.6 kb with 17 exons. Reference sequences are listed in <a class="figpopup" href="/books/NBK447258/table/vps35-pd.T.vps35_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figvps35pdTvps35variantsdiscussedint" rid-ob="figobvps35pdTvps35variantsdiscussedint">Table 2</a>.</p><p><b>Pathogenic variants.</b> The c.1858G&#x0003e;A (p.Asp620Asn) variant in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 15 is the only variant detected with confirmed evidence of pathogenicity. Because this variant is known to occur on different haplotypes, it is likely a mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a>.</p><p>Additional <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>VPS35</i> found in at least one individual with Parkinson disease are listed in <a class="figpopup" href="/books/NBK447258/table/vps35-pd.T.vps35_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figvps35pdTvps35variantsdiscussedint" rid-ob="figobvps35pdTvps35variantsdiscussedint">Table 2</a>. Because the few missense variants found in multiple individuals with Parkinson disease (p.Gly51Ser, p.Pro316Ser, p.Leu774Met) have also been found in controls, the data are currently insufficient to determine pathogenicity of these variants [<a class="bk_pop" href="#vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</a>, <a class="bk_pop" href="#vps35-pd.REF.sharma.2012.721">Sharma et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.verstraeten.2012.1844.e11">Verstraeten et al 2012</a>, <a class="bk_pop" href="#vps35-pd.REF.nuytemans.2013.982">Nuytemans et al 2013</a>].</p><div id="vps35-pd.T.vps35_variants_discussed_in_t" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>VPS35</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447258/table/vps35-pd.T.vps35_variants_discussed_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps35-pd.T.vps35_variants_discussed_in_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_1" rowspan="12" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a></b></td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.151G&#x0003e;A</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly51Ser</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_4" rowspan="13" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018206.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_018206<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_060676.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_060676<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.171G&#x0003e;A</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met57Ile</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.723T&#x0003e;G</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile241Met</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.946C&#x0003e;T</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro316Ser</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1520A&#x0003e;T</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr507Phe</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1570C&#x0003e;T</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg524Trp</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1679T&#x0003e;C</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile560Thr</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1796A&#x0003e;G</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His599Arg</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1819A&#x0003e;G</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met607Val</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2210C&#x0003e;T</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala737Val</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2320C&#x0003e;A</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu774Met</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2359G&#x0003e;A</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu787Lys</td></tr><tr><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1858G&#x0003e;A</td><td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp620Asn</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>VPS35</i> encodes a 796-amino-acid protein with a molecular mass of 92 kd termed VPS35. The VPS35 protein is part of the retromer, an evolutionarily conserved complex that associates with the cytosolic face of endosomes. The retromer is involved in the retrograde transport of transmembrane cargo (receptors, including dopamine receptors, transporters, adhesion molecules, and other proteins) from endosomes to the trans-Golgi network and to the plasma membrane; its cargo proteins are either recycled or degraded.</p><p>The human retromer comprises two assembling subunits: one consists of a trimeric complex of VPS35, VPS26, and VPS29 proteins and is also termed cargo-selective complex, and the other consists of a sortin nexin dimer (SNX). VPS35 forms a horseshoe-shaped alpha-helical solenoid predicted to contain 33 helices [<a class="bk_pop" href="#vps35-pd.REF.lucas.2016.1623">Lucas et al 2016</a>]. It functions as the central platform for binding to other retromer proteins. VPS35 also mediates the association with the WASH complex, which includes FAM21. FAM21 binds to VPS35 through its extended unstructured "tail" <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, thereby allowing WASH-dependent retromer-mediated sorting of proteins (for a review see <a class="bk_pop" href="#vps35-pd.REF.burd.2014.6">Burd &#x00026; Cullen [2014]</a>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>VPS35</i> encoding p.Asp620Asn has been shown to fold correctly and to bind VPS29 and VPS26A normally; however, binding to FAM21 of the WASH complex was perturbed, resulting in impairment of recruitment of the WASH complex to endosomes, retromer-mediated sorting of proteins, and autophagy [<a class="bk_pop" href="#vps35-pd.REF.follett.2014.230">Follett et al 2014</a>, <a class="bk_pop" href="#vps35-pd.REF.mcgough.2014.1670">McGough et al 2014</a>, <a class="bk_pop" href="#vps35-pd.REF.zavodszky.2014a.3828">Zavodszky et al 2014a</a>, <a class="bk_pop" href="#vps35-pd.REF.zavodszky.2014b.2155">Zavodszky et al 2014b</a>]. Of note, perturbed binding to FAM21 is compatible with a partial <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant.</p><p>In addition, p.Asp620Asn has been shown to:</p><ul><li class="half_rhythm"><div>Redistribute endosomes to a perinuclear localization [<a class="bk_pop" href="#vps35-pd.REF.follett.2014.230">Follett et al 2014</a>];</div></li><li class="half_rhythm"><div>Enlarge endosomes [<a class="bk_pop" href="#vps35-pd.REF.follett.2014.230">Follett et al 2014</a>];</div></li><li class="half_rhythm"><div>Disrupt the trafficking of cathepsin D, a lysosome protease responsible for degradation of &#x003b1;-synuclein [<a class="bk_pop" href="#vps35-pd.REF.follett.2014.230">Follett et al 2014</a>];</div></li><li class="half_rhythm"><div>Lose its ability to interact with dopamine receptor D1 (DRD1), causing dysregulation of DRD1 trafficking and impairment of DRD1-mediated dopamine signaling [<a class="bk_pop" href="#vps35-pd.REF.wang.2016.22">Wang et al 2016</a>].</div></li></ul><p><i>VPS35</i> encoding p.Arg524Trp (which remains to be proven to be pathogenic) resulted in the accumulation of intracellular &#x003b1;-synuclein-positive aggregates, while the retromer showed decreased endosomal association and impaired protein trafficking [<a class="bk_pop" href="#vps35-pd.REF.follett.2016.18283">Follett et al 2016</a>].</p><p>In animal models, p.Asp620Asn results:</p><ul><li class="half_rhythm"><div>In mouse: in a reduction of dopamine release in the caudate putamen of <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> VPS35 p.Asp620Asn knock-in mice [<a class="bk_pop" href="#vps35-pd.REF.ishizu.2016.4507">Ishizu et al 2016</a>];</div></li><li class="half_rhythm"><div>In rat: in marked degeneration of substantia nigra dopaminergic neurons, and axonal pathology [<a class="bk_pop" href="#vps35-pd.REF.tsika.2014.4621">Tsika et al 2014</a>];</div></li><li class="half_rhythm"><div>In <i>Drosophila</i>: in poor mobility, shortened life span, and increased sensitivity to rotenone [<a class="bk_pop" href="#vps35-pd.REF.wang.2014.73">Wang et al 2014</a>].</div></li></ul><p><i>VPS35</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> was found to increase Alzheimer disease neuropathology in mice [<a class="bk_pop" href="#vps35-pd.REF.wen.2011.765">Wen et al 2011</a>].</p></div></div><div id="vps35-pd.References"><h2 id="_vps35-pd_References_">References</h2><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.ando.2012.1413">Ando M, Funayama M, Li Y, Kashihara K, Murakami Y, Ishizu N, Toyoda C, Noguchi K, Hashimoto T, Nakano N, Sasaki R, Kokubo Y, Kuzuhara S, Ogaki K, Yamashita C, Yoshino H, Hatano T, Tomiyama H, Hattori N. VPS35 mutation in Japanese patients with typical Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:1413–7.</span> [<a href="/pubmed/22991136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22991136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.antonini.2007.826">Antonini A, Poewe W. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. <span><span class="ref-journal">Lancet Neurol. </span>2007;<span class="ref-vol">6</span>:826–9.</span> [<a href="/pubmed/17706566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17706566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.bandr_sciga.2016.210.e1">Bandr&#x000e9;s-Ciga S, Mencacci NE, Dur&#x000e1;n R, Barrero FJ, Escamilla-Sevilla F, Morgan S, Hehir J, Vives F, Hardy J, Pittman AM. Analysis of the genetic variability in Parkinson's disease from Southern Spain. <span><span class="ref-journal">Neurobiol Aging. </span>2016;<span class="ref-vol">37</span>:210.e1–210.e5.</span> [<a href="/pubmed/26518746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26518746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.berardelli.2013.16">Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. <span><span class="ref-journal">Eur J Neurol. </span>2013;<span class="ref-vol">20</span>:16–34.</span> [<a href="/pubmed/23279440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23279440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.blanckenberg.2014.445.e1">Blanckenberg J, Ntsapi C, Carr JA, Bardien S. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa. <span><span class="ref-journal">Neurobiol Aging. </span>2014;<span class="ref-vol">35</span>:445.e1–3.</span> [<a href="/pubmed/24080171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24080171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.bohlega.2013.215">Bohlega SA, Al-Foghom NB. Drug-induced Parkinson's disease: a clinical review. <span><span class="ref-journal">Neurosciences (Riyadh). </span>2013;<span class="ref-vol">18</span>:215–21.</span> [<a href="/pubmed/23887211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23887211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.bondonguitton.2011.2226">Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL. Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span>:2226–31.</span> [<a href="/pubmed/21674626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21674626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.burd.2014.6">Burd C, Cullen PJ. Retromer: a master conductor of endosome sorting. <span><span class="ref-journal">Cold Spring Harb Perspect Biol. </span>2014:6.</span> [<a href="/pmc/articles/PMC3941235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3941235</span></a>] [<a href="/pubmed/24492709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24492709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.chen.2013.1709.e7">Chen Y, Chen K, Song W, Chen X, Cao B, Huang R, Zhao B, Guo X, Burgunder J, Li J, Shang HF. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. <span><span class="ref-journal">Neurobiol Aging. </span>2013;<span class="ref-vol">34</span>:1709.e7–8.</span> [<a href="/pubmed/23261770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23261770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.deng.2012.e96">Deng H, Xu H, Deng X, Song Z, Zheng W, Gao K, Fan X, Tang J. VPS35 mutation in Chinese Han patients with late-onset Parkinson's disease. <span><span class="ref-journal">Eur J Neurol. </span>2012;<span class="ref-vol">19</span>:e96–7.</span> [<a href="/pubmed/22891780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22891780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.ferreira.2013.5">Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Sch&#x000fc;pbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. <span><span class="ref-journal">Eur J Neurol. </span>2013;<span class="ref-vol">20</span>:5–15.</span> [<a href="/pubmed/23279439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23279439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.follett.2014.230">Follett J, Norwood SJ, Hamilton NA, Mohan M, Kovtun O, Tay S, Zhe Y, Wood SA, Mellick GD, Silburn PA, Collins BM, Bugarcic A, Teasdale RD. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer. <span><span class="ref-journal">Traffic. </span>2014;<span class="ref-vol">15</span>:230–44.</span> [<a href="/pubmed/24152121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24152121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.follett.2016.18283">Follett J, Bugarcic A, Yang Z, Ariotti N, Norwood SJ, Collins BM, Parton RG, Teasdale RD. Parkinson disease-linked Vps35 R524W mutation impairs the endosomal association of retromer and induces &#x003b1;-Synuclein aggregation. <span><span class="ref-journal">J Biol Chem. </span>2016;<span class="ref-vol">291</span>:18283–98.</span> [<a href="/pmc/articles/PMC5000076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5000076</span></a>] [<a href="/pubmed/27385586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27385586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.fujioka.2014">Fujioka S, Wszolek ZK. Genetic parkinsonism. In: Erik Walters, Christian Baumann, eds. <em>Parkinson Disease and Other Movement Disorders</em>. VU University Press. 2014:321-361.</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.gagliardi.2014.2422.e1">Gagliardi M, Annesi G, Tarantino P, Nicoletti G, Quattrone A. Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy. <span><span class="ref-journal">Neurobiol Aging. </span>2014;<span class="ref-vol">35</span>:2422.e1–2.</span> [<a href="/pubmed/24854799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24854799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.guella.2012.800">Guella I, Sold&#x000e0; G, Cilia R, Pezzoli G, Asselta R, Duga S, Goldwurm S. The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:800–1.</span> [<a href="/pubmed/22278960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22278960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.guo.2012.983">Guo JF, Sun QY, Lv ZY, Yu RL, Li K, Zhang YH, Tian JY, Xia K, Yan XX, Tang BS. VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2012;<span class="ref-vol">18</span>:983–5.</span> [<a href="/pubmed/22673036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22673036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.ishizu.2016.4507">Ishizu N, Yui D, Hebisawa A, Aizawa H, Cui W, Fujita Y, Hashimoto K, Ajioka I, Mizusawa H, Yokota T, Watase K. Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice. <span><span class="ref-journal">Hum Mol Genet. </span>2016;<span class="ref-vol">25</span>:4507–17.</span> [<a href="/pubmed/28173004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28173004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.kalinderi.2015.113">Kalinderi K, Bostantjopoulou S, Katsarou Z, Dimikiotou M, Fidani L. D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population. <span><span class="ref-journal">Neurosci Lett. </span>2015;<span class="ref-vol">606</span>:113–6.</span> [<a href="/pubmed/26300542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26300542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.kranick.2010.665">Kranick SM, Mowry EM, Colcher A, Horn S, Golbe LI. Movement disorders and pregnancy: a review of the literature. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:665–71.</span> [<a href="/pubmed/20437535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20437535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.kumar.2012.1360">Kumar KR, Weissbach A, Heldmann M, Kasten M, Tunc S, Sue CM, Svetel M, Kosti&#x00107; VS, Segura-Aguilar J, Ramirez A, Simon DK, Vieregge P, M&#x000fc;nte TF, Hagenah J, Klein C, Lohmann K. Frequency of the D620N mutation in VPS35 in Parkinson disease. <span><span class="ref-journal">Arch Neurol. </span>2012;<span class="ref-vol">69</span>:1360–4.</span> [<a href="/pubmed/22801713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22801713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.lek.2016.285">Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, et al.  Analysis of protein-coding genetic variation in 60,706 humans. <span><span class="ref-journal">Nature. </span>2016;<span class="ref-vol">536</span>:285–91.</span> [<a href="/pmc/articles/PMC5018207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5018207</span></a>] [<a href="/pubmed/27535533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27535533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.lesage.2012.1449">Lesage S, Condroyer C, Klebe S, Honor&#x000e9; A, Tison F, Brefel-Courbon C, D&#x000fc;rr A, Brice A, et al.  Identification of VPS35 mutations replicated in French families with Parkinson disease. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1449–50.</span> [<a href="/pubmed/22517097" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22517097</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.lill.2016.386">Lill CM. Genetics of Parkinson's disease. <span><span class="ref-journal">Mol Cell Probes. </span>2016;<span class="ref-vol">30</span>:386–396.</span> [<a href="/pubmed/27818248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27818248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.lucas.2016.1623">Lucas M, Gershlick DC, Vidaurrazaga A, Rojas AL, Bonifacino JS, Hierro A. Structural mechanism for cargo recognition by the retromer complex. <span><span class="ref-journal">Cell. </span>2016;<span class="ref-vol">167</span>:1623–35.e14.</span> [<a href="/pmc/articles/PMC5147500/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5147500</span></a>] [<a href="/pubmed/27889239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27889239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.marras.2012.1016">Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1016–24.</span> [<a href="/pmc/articles/PMC3310311/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3310311</span></a>] [<a href="/pubmed/22454269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22454269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.mcgough.2014.1670">McGough IJ, Steinberg F, Jia D, Barbuti PA, McMillan KJ, Heesom KJ, Whone AL, Caldwell MA, Billadeau DD, Rosen MK, Cullen PJ. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation. <span><span class="ref-journal">Curr Biol. </span>2014;<span class="ref-vol">24</span>:1670–6.</span> [<a href="/pmc/articles/PMC4110399/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4110399</span></a>] [<a href="/pubmed/24980502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24980502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.nuytemans.2013.982">Nuytemans K, Bademci G, Inchausti V, Dressen A, Kinnamon DD, Mehta A, Wang L, Z&#x000fc;chner S, Beecham GW, Martin ER, Scott WK, Vance JM. Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:982–9.</span> [<a href="/pmc/articles/PMC3653206/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3653206</span></a>] [<a href="/pubmed/23408866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23408866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.odin.2015.1133">Odin P, Ray Chaudhuri K, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P, Krauss JK, Henriksen T, Katzenschlager R, Antonini A, Rascol O, Poewe W, et al.  Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an international survey and discussion program. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2015;<span class="ref-vol">21</span>:1133–44.</span> [<a href="/pubmed/26233582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26233582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.oertel.a">Oertel WH, Berardelli A, Bloem BR, et al. Early (uncomplicated) Parkinson's disease. In: Gilhus NE, Barnes M, Brainin M, eds. <em>European Handbook of Neurological Management.</em> Vol 1. 2 ed. Oxford: Blackwell Publishing Ltd; 2011a: 217&#x02013;36.</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.oertel.b">Oertel WH, Berardelli A, Bloem BR, et al. Late (complicated) Parkinson's disease. In: Gilhus NE, Barnes M, Brainin M, eds. <em>European Handbook of Neurological Management</em>. Vol 1. 2 ed. Oxford: Blackwell Publishing Ltd; 2011b: 237&#x02013;67.</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.postuma.2015.1591">Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2015;<span class="ref-vol">30</span>:1591–601.</span> [<a href="/pubmed/26474316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26474316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.robottom.2008.1799">Robottom BJ, Mullins RJ, Shulman LM. Pregnancy in Parkinson's disease: case report and discussion. <span><span class="ref-journal">Expert Rev Neurother. </span>2008;<span class="ref-vol">8</span>:1799–805.</span> [<a href="/pubmed/19086876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19086876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Al Turki S, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.roveletlecrux.2015.1046">Rovelet-Lecrux A, Charbonnier C, Wallon D, Nicolas G, Seaman MN, Pottier C, Breusegem SY, Mathur PP, Jenardhanan P, Le Guennec K, Mukadam AS, Quenez O, Coutant S, Rousseau S, Richard AC, Boland A, Deleuze JF, Frebourg T, Hannequin D, Campion D, et al.  De novo deleterious genetic variations target a biological network centered on A&#x003b2; peptide in early-onset Alzheimer disease. <span><span class="ref-journal">Mol Psychiatry. </span>2015;<span class="ref-vol">20</span>:1046–56.</span> [<a href="/pubmed/26194182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26194182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.scott.2005.1078">Scott M, Chowdhury M. Pregnancy in Parkinson's disease: unique case report and review of the literature. <span><span class="ref-journal">Mov Disord. </span>2005;<span class="ref-vol">20</span>:1078–9.</span> [<a href="/pubmed/16001415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16001415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.seppi.2011.s42">Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span> Suppl 3:S42–80.</span> [<a href="/pmc/articles/PMC4020145/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4020145</span></a>] [<a href="/pubmed/22021174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22021174</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.sharma.2012.721">Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilari&#x000f1;o-G&#x000fc;ell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Kr&#x000fc;ger R, et al.  A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:721–6.</span> [<a href="/pmc/articles/PMC3488700/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3488700</span></a>] [<a href="/pubmed/23125461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23125461</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.sheerin.2012.838.e1">Sheerin UM, Charlesworth G, Bras J, Guerreiro R, Bhatia K, Foltynie T, Limousin P, Silveira-Moriyama L, Lees A, Wood N. Screening for VPS35 mutations in Parkinson's disease. <span><span class="ref-journal">Neurobiol Aging. </span>2012;<span class="ref-vol">33</span>:838.e1–5.</span> [<a href="/pmc/articles/PMC3629567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3629567</span></a>] [<a href="/pubmed/22154191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22154191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.struhal.2014.755">Struhal W, Presslauer S, Spielberger S, Zimprich A, Auff E, Bruecke T, Poewe W, Ransmayr G, et al.  VPS35 Parkinson's disease phenotype resembles the sporadic disease. <span><span class="ref-journal">J Neural Transm (Vienna). </span>2014;<span class="ref-vol">121</span>:755–9.</span> [<a href="/pubmed/24557499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24557499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.sudhaman.2013.2442.e1">Sudhaman S, Behari M, Govindappa ST, Muthane UB, Juyal RC, Thelma BK. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians. <span><span class="ref-journal">Neurobiol Aging. </span>2013;<span class="ref-vol">34</span>:2442.e1–3.</span> [<a href="/pubmed/23726718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23726718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.trinh.2014.1535">Trinh J, Guella I, Farrer MJ. Disease penetrance of late-onset parkinsonism: a meta-analysis. <span><span class="ref-journal">JAMA Neurol. </span>2014;<span class="ref-vol">71</span>:1535–9.</span> [<a href="/pubmed/25330418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25330418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.tsika.2014.4621">Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin UM, Lees A, Troncoso JC, Lewis PA, Bandopadhyay R, Schneider BL, Moore DJ. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:4621–38.</span> [<a href="/pmc/articles/PMC4119414/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4119414</span></a>] [<a href="/pubmed/24740878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24740878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.t_r_k.2016.135">T&#x000f6;r&#x000f6;k R, Z&#x000e1;dori D, T&#x000f6;r&#x000f6;k N, Csility &#x000c9;, V&#x000e9;csei L, Kliv&#x000e9;nyi P. An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease. <span><span class="ref-journal">Neurosci Lett. </span>2016;<span class="ref-vol">610</span>:135–8.</span> [<a href="/pubmed/26547032" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26547032</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.trenkwalder.2015.1023">Trenkwalder C, Chaudhuri KR, Garc&#x000ed;a Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-D&#x000f6;ring F, Henriksen T, Sesar &#x000c1;, Poewe W, Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Mart&#x000ed;nez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K, et al.  Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease: clinical practice recommendations. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2015;<span class="ref-vol">21</span>:1023–30.</span> [<a href="/pubmed/26189414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26189414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.verstraeten.2012.1844.e11">Verstraeten A, Wauters E, Crosiers D, Meeus B, Corsmit E, Elinck E, Mattheijssens M, Peeters K, Cras P, Pickut B, Vandenberghe R, Engelborghs S, De Deyn PP, Van Broeckhoven C, Theuns J. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. <span><span class="ref-journal">Neurobiol Aging. </span>2012;<span class="ref-vol">33</span>:1844.e11–3.</span> [<a href="/pubmed/22336192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22336192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Ghika J, Hentati F, Krygowska-Wajs A, Lynch T, Melamed E, Rajput A, Rajput AH, Solida A, Wu RM, Uitti RJ, Wszolek ZK, Vingerhoets F, Farrer MJ. VPS35 mutations in Parkinson disease. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:162–7.</span> [<a href="/pmc/articles/PMC3135796/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135796</span></a>] [<a href="/pubmed/21763482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21763482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.wang.2016.22">Wang C, Niu M, Zhou Z, Zheng X, Zhang L, Tian Y, Yu X, Bu G, Xu H, Ma Q, Zhang YW. VPS35 regulates cell surface recycling and signaling of dopamine receptor D1. <span><span class="ref-journal">Neurobiol Aging. </span>2016;<span class="ref-vol">46</span>:22–31.</span> [<a href="/pmc/articles/PMC5018432/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5018432</span></a>] [<a href="/pubmed/27460146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27460146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.wang.2014.73">Wang HS, Toh J, Ho P, Tio M, Zhao Y, Tan EK. In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila. <span><span class="ref-journal">Mol Brain. </span>2014;<span class="ref-vol">7</span>:73.</span> [<a href="/pmc/articles/PMC4193144/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4193144</span></a>] [<a href="/pubmed/25288323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25288323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.wen.2011.765">Wen L, Tang FL, Hong Y, Luo SW, Wang CL, He W, Shen C, Jung JU, Xiong F, Lee DH, Zhang QG, Brann D, Kim TW, Yan R, Mei L, Xiong WC. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. <span><span class="ref-journal">J Cell Biol. </span>2011;<span class="ref-vol">195</span>:765–79.</span> [<a href="/pmc/articles/PMC3257571/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257571</span></a>] [<a href="/pubmed/22105352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22105352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.wider.2008.465">Wider C, Skipper L, Solida A, Brown L, Farrer M, Dickson D, Wszolek ZK, Vingerhoets FJ. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2008;<span class="ref-vol">14</span>:465–70.</span> [<a href="/pubmed/18342564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18342564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.zavodszky.2014a.3828">Zavodszky E, Seaman MN, Moreau K, Jimenez-Sanchez M, Breusegem SY, Harbour ME, Rubinsztein DC. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. <span><span class="ref-journal">Nat Commun. </span>2014a;<span class="ref-vol">5</span>:3828.</span> [<a href="/pmc/articles/PMC4024763/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4024763</span></a>] [<a href="/pubmed/24819384" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24819384</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.zavodszky.2014b.2155">Zavodszky E, Seaman MN, Rubinsztein DC. VPS35 Parkinson mutation impairs autophagy via WASH. <span><span class="ref-journal">Cell Cycle. </span>2014b;<span class="ref-vol">13</span>:2155–6.</span> [<a href="/pmc/articles/PMC4111667/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4111667</span></a>] [<a href="/pubmed/24963965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24963965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.zesiewicz.2010.924">Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ, et al.  Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">74</span>:924–31.</span> [<a href="/pubmed/20231670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20231670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.zhang.2012.638">Zhang Y, Chen S, Xiao Q, Cao L, Liu J, Rong TY, Ma JF, Wang G, Wang Y, Chen SD. Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2012;<span class="ref-vol">18</span>:638–40.</span> [<a href="/pubmed/22410496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22410496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps35-pd.REF.zimprich.2011.168">Zimprich A, Benet-Pag&#x000e8;s A, Struhal W, Graf E, Eck SH, Offman MN, Haubenberger D, Spielberger S, Schulte EC, Lichtner P, Rossle SC, Klopp N, Wolf E, Seppi K, Pirker W, Presslauer S, Mollenhauer B, Katzenschlager R, Foki T, Hotzy C, Reinthaler E, Harutyunyan A, Kralovics R, Peters A, Zimprich F, Br&#x000fc;cke T, Poewe W, Auff E, Trenkwalder C, Rost B, Ransmayr G, Winkelmann J, Meitinger T, Strom TM. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:168–75.</span> [<a href="/pmc/articles/PMC3135812/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135812</span></a>] [<a href="/pubmed/21763483" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21763483</span></a>]</div></li></ul></div><div id="vps35-pd.Chapter_Notes"><h2 id="_vps35-pd_Chapter_Notes_">Chapter Notes</h2><div id="vps35-pd.Acknowledgments"><h3>Acknowledgments</h3><p>AD is supported by the Max Kade foundation and the gift from Carl Edward Bolch, Jr and Susan Bass Bolch. This work is also supported by NINDS R01 NS078086 (OAR). ZKW is partially supported by the NIH/NINDS P50 NS072187, NIH/NIA (primary) and NIH/NINDS (secondary) 1U01AG045390-01A1, Mayo Clinic Center for Regenerative Medicine, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C and Sarah K Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida), the gift from Carl Edward Bolch Jr and Susan Bass Bolch, the Sol Goldman Charitable Trust, and Donald G and Jodi P Heeringa.</p></div><div id="vps35-pd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 August 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>15 December 2016 (ad) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK447258</span><span class="label">PMID: <a href="/pubmed/28796472" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">28796472</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/vps13d-md/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/porphyria-var/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK447258&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK447258/?report=reader">PubReader</a></li><li><a href="/books/NBK447258/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK447258" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK447258" style="display:none" title="Cite this Page"><div class="bk_tt">Deutschländer A, Ross OA, Wszolek ZK. VPS35-Related Parkinson Disease. 2017 Aug 10. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK447258/pdf/Bookshelf_NBK447258.pdf">PDF version of this page</a> (224K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#vps35-pd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#vps35-pd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#vps35-pd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#vps35-pd.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#vps35-pd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#vps35-pd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#vps35-pd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#vps35-pd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#vps35-pd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#vps35-pd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#vps35-pd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55737[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">VPS35</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4433752" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4433752" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4433752" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4433752" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301387" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">LRRK2</i> Parkinson Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">LRRK2</i> Parkinson Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saunders-Pullman R, Raymond D, Elango S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301681" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Furukawa Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27577098" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Current and experimental treatments of Parkinson disease: A guide for neuroscientists.</a><span class="source">[J Neurochem. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Current and experimental treatments of Parkinson disease: A guide for neuroscientists.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Oertel W, Schulz JB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurochem. 2016 Oct; 139 Suppl 1:325-337. Epub 2016 Aug 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301792" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PINK1</i> Type of Young-Onset Parkinson Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PINK1</i> Type of Young-Onset Parkinson Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schneider SA, Klein C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28985717" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review.</a><span class="source">[BMC Neurol. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen YF, Chang YY, Lan MY, Chen PL, Lin CH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Neurol. 2017 Oct 6; 17(1):191. Epub 2017 Oct 6.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=28796472" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=28796472" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410fedde089116993fff4">VPS35-Related Parkinson Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">VPS35-Related Parkinson Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:46:38-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CAEC7E03FDE4100000000079602C9&amp;ncbi_session=CE8CAEC7E0410FD1_1942SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK447258%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK447258&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK447258/&amp;ncbi_pagename=VPS35-Related Parkinson Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CAEC7E0410FD1_1942SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>